Gourapura J Renukaradhya Selected Research

Nanovaccines

1/2021	Immunity and Protective Efficacy of Mannose Conjugated Chitosan-Based Influenza Nanovaccine in Maternal Antibody Positive Pigs.
1/2020	Oral Deliverable Mucoadhesive Chitosan-Salmonella Subunit Nanovaccine for Layer Chickens.
1/2020	Intranasal Delivery of Inactivated Influenza Virus and Poly(I:C) Adsorbed Corn-Based Nanoparticle Vaccine Elicited Robust Antigen-Specific Cell-Mediated Immune Responses in Maternal Antibody Positive Nursery Pigs.
1/2020	Immune Response to Salmonella Enteritidis Infection in Broilers Immunized Orally With Chitosan-Based Salmonella Subunit Nanoparticle Vaccine.
1/2018	Intranasal delivery of influenza antigen by nanoparticles, but not NKT-cell adjuvant differentially induces the expression of B-cell activation factors in mice and swine.
1/2018	Mucosal Immunity and Protective Efficacy of Intranasal Inactivated Influenza Vaccine Is Improved by Chitosan Nanoparticle Delivery in Pigs.
1/2017	Polyanhydride nanovaccine against swine influenza virus in pigs.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Gourapura J Renukaradhya Research Topics

Disease

19	Infections 02/2022 - 04/2007
12	Human Influenza (Influenza) 01/2021 - 01/2016
11	Porcine Reproductive and Respiratory Syndrome (PRRS) 06/2016 - 05/2011
10	Orthomyxoviridae Infections 01/2021 - 11/2010
4	Fever (Fevers) 01/2018 - 04/2011
4	Viremia 08/2016 - 05/2011
3	Virus Diseases (Viral Diseases) 01/2020 - 01/2012
3	Communicable Diseases (Infectious Diseases) 01/2020 - 12/2008
2	COVID-19 02/2022 - 01/2021
2	Asthma (Bronchial Asthma) 01/2022 - 04/2011
2	Pneumonia (Pneumonitis) 01/2022 - 11/2009
2	Reinfection 12/2015 - 01/2014
2	Neoplasms (Cancer) 12/2008 - 06/2008
1	Conjunctivitis 01/2022
1	Allergic Rhinitis 01/2022
1	Seasonal Allergic Rhinitis (Hay Fever) 01/2022
1	Enteritis 06/2020
1	Salmonella Infections (Salmonellosis) 01/2020
1	Zoonoses 01/2020
1	T-Cell Lymphoma (Lymphoma, T Cell) 01/2017
1	Bovine Brucellosis (Bang's Disease) 01/2017
1	Brucellosis (Malta Fever) 01/2016
1	Respiratory Tract Infections (Respiratory Tract Infection) 12/2015
1	Hemorrhage 04/2011
1	Lung Diseases (Lung Disease) 10/2010
1	Coinfection 10/2010
1	Inflammation (Inflammations) 04/2009
1	Vesicular Stomatitis 12/2008
1	B-Cell Lymphoma (Lymphoma, B Cell) 06/2008
1	Smallpox (Variola) 10/2006

Drug/Important Bio-Agent (IBA)

37	VaccinesIBA 02/2022 - 10/2006
8	Proteins (Proteins, Gene)FDA Link 01/2022 - 12/2008
7	ChitosanIBA 01/2022 - 01/2018
7	NanovaccinesIBA 01/2021 - 01/2017
7	AntigensIBA 05/2020 - 12/2008
7	CytokinesIBA 01/2018 - 06/2008
6	AntibodiesIBA 01/2021 - 08/2016
3	Influenza Vaccines (Influenza Vaccine)FDA Link 01/2021 - 12/2016
3	Neutralizing AntibodiesIBA 01/2021 - 05/2011
3	Viral RNAIBA 01/2021 - 03/2016
3	Peptides (Polypeptides)IBA 05/2020 - 01/2016
3	Poly I-CIBA 05/2020 - 01/2020
2	Mannose (D-Mannose)IBA 01/2022 - 01/2021
2	RNA (Ribonucleic Acid)IBA 01/2021 - 03/2016
2	Immunoglobulin A (IgA)IBA 01/2019 - 12/2015
2	Transcription Factors (Transcription Factor)IBA 01/2019 - 01/2018
2	Immunoglobulin G (IgG)IBA 06/2016 - 12/2015
2	Antiviral Agents (Antivirals)IBA 01/2016 - 10/2006
2	Inactivated VaccinesIBA 06/2015 - 09/2013
1	SARS-CoV-2 spike proteinIBA 02/2022
1	Recombinant ProteinsIBA 02/2022
1	Aluminum Hydroxide (Algeldrate)FDA Link 01/2022
1	SqualeneIBA 01/2022
1	EmulsionsIBA 01/2022
1	AllergensIBA 01/2022
1	EpitopesIBA 01/2021
1	Pancreatic Elastase (Elastase)IBA 01/2021
1	Secretory Immunoglobulin A (SIgA)IBA 05/2020
1	polyglucosanIBA 05/2020
1	Salmonella VaccinesIBA 01/2020
1	Superoxide Dismutase-1IBA 01/2020
1	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 01/2018
1	Liposomes (Liposome)IBA 01/2018
1	Neurofibromin 1 (Neurofibromin)IBA 01/2017
1	Monatide (IMS 3015)IBA 12/2016
1	Membrane Proteins (Integral Membrane Proteins)IBA 06/2016
1	LigandsIBA 04/2016
1	CPG-oligonucleotideIBA 03/2016
1	Viral VaccinesIBA 03/2016
1	Immunologic Factors (Immunomodulators)IBA 01/2016
1	Subunit VaccinesIBA 06/2015
1	Reactive Oxygen Species (Oxygen Radicals)IBA 12/2011
1	Interleukin-12 (IL 12)IBA 05/2011
1	ArginaseIBA 05/2011
1	C-glycosideIBA 04/2011
1	Interleukin-4 (Interleukin 4)IBA 04/2011
1	hydroxide ionIBA 11/2010
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 08/2010
1	Interferon-alpha (Interferon Alfa)IBA 11/2009
1	DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)IBA 11/2009
1	InterleukinsIBA 11/2009
1	EnzymesIBA 04/2009
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 04/2009
1	CholesterolIBA 04/2009
1	p38 Mitogen-Activated Protein KinasesIBA 12/2008
1	LipidsIBA 12/2008
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 06/2008

Therapy/Procedure

1	Immunotherapy 01/2022
1	Therapeutics 01/2022
1	Intranasal Administration 01/2022
1	Hematopoietic Stem Cell Transplantation 04/2007